STOCK FUTURES DECLINE AS MICRON WARNS, CHIPMAKERS FALL

Memory chipmaker warns Q4 revenue may come in on par with or below bottom end of forecast range

Qiagen N.V. (QGEN)

NYSE - NYSE Delayed Price. Currency in USD

Add to watchlist

49.45

-0.25

(-0.50%)

At close: 04:00PM EDT

49.08

-0.37

(-0.75%)

Pre-Market:

07:02AM EDT

Loading interactive chart...

Zacks
QIAGEN (QGEN) Q2 Earnings Top Estimates, Margins Decline
QIAGEN (QGEN) posts better-than-expected results for the second quarter and raises its sales and earnings outlook for 2022 amid the uncertain macroeconomic environment.
Business Wire
QIAGEN adds new biopharma products to QIAcuity digital PCR portfolio and launches Expert Custom Assay Design Service
HILDEN, Germany & GERMANTOWN, Md., July 27, 2022--QIAGEN (NYSE: QGEN; Frankfurt Prime Standard: QIA) announced today a series of enhancements for its QIAcuity series of digital PCR (dPCR) instruments designed to drive greater use among customers, particularly those involved in the biopharma industry:
Zacks
Qiagen (QGEN) Beats Q2 Earnings and Revenue Estimates
Qiagen (QGEN) delivered earnings and revenue surprises of 13.33% and 3.50%, respectively, for the quarter ended June 2022. Do the numbers hold clues to what lies ahead for the stock?